tiprankstipranks
Trending News
More News >
Exor NV (NL:EXO)
:EXO

Exor (EXO) AI Stock Analysis

Compare
11 Followers

Top Page

NL:EXO

Exor

(EXO)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 4o)
Rating:49Neutral
Price Target:
€79.00
▲(3.47% Upside)
Exor's overall stock score is primarily influenced by its mixed financial performance and bearish technical indicators. While the company shows strong profitability and a robust balance sheet, the significant revenue decline and cash flow issues are concerning. The technical analysis indicates a downtrend, and the low P/E ratio suggests potential undervaluation, but the modest dividend yield limits income potential.

Exor (EXO) vs. iShares MSCI Netherlands ETF (EWN)

Exor Business Overview & Revenue Model

Company DescriptionExor N.V. is a diversified holding company based in the Netherlands, primarily involved in various sectors including automotive, agriculture, and media. It is known for its significant investments in leading companies such as Fiat Chrysler Automobiles (now part of Stellantis), Ferrari, and The Economist Group. Exor's strategy revolves around long-term value creation through active management and strategic partnerships in its portfolio companies, focusing on innovation and sustainable growth.
How the Company Makes MoneyExor generates revenue primarily through its investments in publicly traded and private companies. Its key revenue streams include dividends and capital gains from its equity holdings, particularly in automotive and media sectors. The company also benefits from strategic partnerships and joint ventures, which enhance its investment portfolio's value. Exor's revenue is significantly bolstered by the performance of its major subsidiaries, including Stellantis and Ferrari, where it holds substantial stakes. Additionally, Exor may engage in the sale of assets or restructuring of its investments to realize gains, further contributing to its financial performance.

Exor Earnings Call Summary

Earnings Call Date:Sep 17, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Apr 01, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted significant achievements, such as the strong performance of Lingotto and a successful share buyback that increased NAV per share. However, these were balanced by challenges like a decrease in gross asset value, negative TSR, and poor share price movements of key investments like Stellantis and Philips. Overall, the sentiment is neutral, as the highlights and lowlights are balanced.
Q2-2025 Updates
Positive Updates
Outperformance of NAV Per Share
NAV per share outperformed the MSCI World Index by about 5% due to a €1 billion buyback. The NAV per share saw an increase of 0.9% with 3.2% attributed to the buyback.
Strong Performance from Lingotto
Lingotto performed exceptionally with an 11% increase, mainly from the public investment part, despite a declining market.
Successful Monetization and Healthy Debt Ratio
Monetized €3 billion of Ferrari stake and maintained a healthy debt ratio at 5.5% of GAV, providing good firepower for future investments.
Strong Dividend Inflows
Received strong dividend inflows of €624 million, contributing to a healthy cash position of €1.5 billion.
Reduction in Gross Debt
Gross debt reduced to €3.5 billion from €4.1 billion, demonstrating effective debt management.
Negative Updates
Decrease in Gross Asset Value
Gross asset value decreased by €2.5 billion, affected by value changes and the buyback.
Disappointing Share Price Movements
Stellantis and Philips both experienced disappointing share price movements, affecting overall performance.
Negative Total Shareholder Return (TSR)
Despite outperforming the market, the TSR was negative, signaling a need for improvement.
Impact of Foreign Exchange Movements
The performance was negatively affected by a €427 million negative FX impact, particularly on Exor Ventures and reinsurance vehicles.
Company Guidance
During Exor's Half Year 2025 Results Conference Call, several key metrics were highlighted by Chief Financial Officer Guido de Boer. The company reported that its net asset value (NAV) per share outperformed the MSCI World Index by approximately 5%, aided by a €1 billion buyback. Despite a €2.5 billion decrease in gross asset value (GAV) due to value changes and the buyback, the NAV per share grew by 0.9%. The company's debt ratio was noted to be healthy at 5.5% of GAV. Exor also monetized €3 billion from its Ferrari stake, enhancing its investment capabilities. Additionally, Lingotto's performance was particularly strong with an 11% increase, driven by public investments despite a declining market. The company invested €1 billion in new ventures, with significant allocations to Philips and Juventus, and realized €3.5 billion from disposals. Overall, Exor continues to focus on outperforming both on a relative and absolute basis, with a commitment to strategic investments and enhancing shareholder value.

Exor Financial Statement Overview

Summary
Income Statement
45
Neutral
Balance Sheet
60
Neutral
Cash Flow
40
Negative
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Exor Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price76.35
Price Trends
50DMA
73.72
Negative
100DMA
79.22
Negative
200DMA
81.98
Negative
Market Momentum
MACD
-0.48
Negative
RSI
48.42
Neutral
STOCH
77.26
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:EXO, the sentiment is Neutral. The current price of 76.35 is above the 20-day moving average (MA) of 72.21, above the 50-day MA of 73.72, and below the 200-day MA of 81.98, indicating a neutral trend. The MACD of -0.48 indicates Negative momentum. The RSI at 48.42 is Neutral, neither overbought nor oversold. The STOCH value of 77.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NL:EXO.

Exor Peers Comparison

Overall Rating
UnderperformOutperform
Sector (―)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
€1.81B16.2025.34%2.46%11.67%36.03%
74
Outperform
€2.52B18.7611.89%2.69%3.64%-22.13%
73
Outperform
€4.07B9.0015.92%4.26%-3.32%15.52%
63
Neutral
€3.18B13.3121.45%2.83%-2.02%24.14%
60
Neutral
€3.01B20.336.13%4.04%-4.31%-50.34%
49
Neutral
€23.29B0.570.68%
* Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NL:EXO
Exor
72.55
-14.51
-16.66%
NL:AALB
Aalberts Industries N.V.
27.96
-4.81
-14.68%
NL:ARCAD
Arcadis NV
35.28
-22.38
-38.81%
NL:BAMNB
Koninklijke Bam Groep NV
9.28
5.23
129.08%
NL:HEIJM
Heijmans N.V.
66.75
36.79
122.77%
NL:VPK
Royal Vopak NV
37.54
-3.45
-8.42%

Exor Corporate Events

Exor N.V. Earnings Call: Balancing Achievements and Challenges
Sep 20, 2025

Exor N.V. (OTC) recently held its earnings call, which painted a picture of balanced achievements and challenges. The company celebrated significant successes, such as the robust performance of Lingotto and a strategic share buyback that boosted NAV per share. However, these positives were tempered by issues like a decrease in gross asset value, negative total shareholder return (TSR), and disappointing share price movements of key investments such as Stellantis and Philips. This mix of highs and lows resulted in a neutral overall sentiment during the call.

Exor N.V. Reports Strong H1 2025 Performance
Sep 19, 2025

Exor N.V. is a diversified holding company based in Amsterdam, primarily engaged in managing a portfolio of companies across various industries, including automotive, reinsurance, and media. The company is known for its strategic investments and significant holdings in well-known brands such as Ferrari and Stellantis.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 10, 2025